Mangini, Neha S <br/><br/>
Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.  [electronic resource] 

 -  The Annals of pharmacotherapy  Nov 2015 
 - 1252-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1542-6270 
<br/><br/><label>Standard No.: </label>10.1177/1060028015602273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Disease-Free Survival<br/>Estradiol--analogs & derivatives<br/>Female<br/>Fulvestrant<br/>Humans<br/>Letrozole<br/>Neoplasms, Hormone-Dependent--drug therapy<br/>Nitriles--administration & dosage<br/>Piperazines--therapeutic use<br/>Pyridines--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Receptor, ErbB-2--metabolism<br/>Triazoles--administration & dosage<br/>United States